EFDID: 167539EFD: View Filing

Issuer: Thetis Pharmaceuticals LLC (0001528491) - D/A

Accession: 0001528491-17-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001528491
  • Entity Name:
    Thetis Pharmaceuticals LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    CONNECTICUT
  • Year of Inc:
    Over 5 years ago
  • Address:
    167 OLD POST ROAD
    2ND FLOOR
    SOUTHPORT, CT 06890
  • Persons:
    Related Persons 5
    Gary F Mathias
    Executive Officer, Director 
    Manager & Chief Executive Officer
    Walter Ogier
    Director 
    Manager
    Frank C Sciavolino
    Executive Officer, Director 
    Manager, President and Chief Scientific Officer
    David M Wurzer
    Director 
    Manager
    Dennis F Willson
    Director 
    Manager
EDGAR: Offering Information
  • Accession Date:
    01/17/2017
  • First Sale Date:
    06/17/2016
  • Offering Amount:
    $8,000,062
  • Amount Sold:
    $4,105,495
  • Amount Remaining:
    $3,894,567
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Fairport Capital, Inc. 15034 Fairport Capital, Inc. 15034 All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Thetis Pharmaceuticals LLCGary F. MathiasGary F. MathiasManager & CEO2017-01-13
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Jan. 17, 2017 167539: 0001528491-17-000001 Thetis Pharmaceuticals LLC
Offer Amount: $8,000,062
Amount Sold: $4,105,495
Remaining: $3,894,567
D Jun. 27, 2016 167539: 0001528491-16-000002 Thetis Pharmaceuticals LLC
Offer Amount: $5,000,059
Amount Sold: $3,333,851
Remaining: $1,666,208